Jan 27, 2021
Abbott Reports Fourth-Quarter 2020 Results; Issues Strong Double-Digit Growth Forecast for 2021
Jan 26, 2021
Abbott's Panbio Rapid Antigen Test Receives CE Mark for Asymptomatic Screening and Self-Administered Sample Collection with Nasal Swab
Jan 20, 2021
Abbott Receives Expanded Medicare Reimbursement for First-Of-Its-Kind MitraClip(TM) Device
Jan 14, 2021
Abbott to Launch the NeuroSphere(TM) myPath(TM) Digital Health App Designed to Track and Report Pain Relief in Chronic Pain Patients With Physicians Prior to Device Implant
Jan 11, 2021
Abbott Receives FDA 510(k) Clearance for the First Rapid Handheld Blood Test for Concussions
Dec 22, 2020
As Vaccines Roll Out, Americans See COVID-19 Testing as Important Partner
Dec 18, 2020
Abbott to Present at J.P. Morgan Healthcare Conference
Dec 17, 2020
FDA Approves Labeling Update for Abbott's HeartMate 3 Heart Pump for use in Pediatric Patients
Dec 15, 2020
Abbott Receives CE Mark for its COVID-19 IgG Quantitative Antibody Blood Test
Dec 14, 2020
Abbott Develops New Pedialyte® Hydration Solution to Help Support Immune Health
Dec 11, 2020
Abbott Increases Quarterly Dividend by 25%
Dec 02, 2020
Abbott's FreeStyle Libre 2 Now Approved for Adults and Children with Diabetes in Canada, Featuring Unsurpassed 14-Day Accuracy and Optional Alarms
Nov 18, 2020
Abbott Becomes First Anchor Sponsor of American Diabetes Association's Health Equity Now Initiative to Advance Access to Care and Technology for People with Diabetes
Nov 10, 2020
Abbott Announces the U.S. Launch of the IonicRF(TM) Generator for Use in Patients Living With Chronic Pain
Oct 30, 2020
Abbott Wins Prestigious Prix Galien USA Award for First-of-its-Kind MitraClip(TM) Device
Oct 21, 2020
Abbott Reports Third-Quarter 2020 Results; Achieves Strong Double-Digit Earnings Growth and Raises Guidance
Oct 19, 2020
Improved Mental and Physical Condition is Directly Linked to Nutrition, Study Shows
Oct 12, 2020
Abbott Receives FDA Emergency Use Authorization for its COVID-19 IgM Antibody Blood Test
Oct 07, 2020
Abbott Releases ID NOW(TM) COVID-19 Interim Clinical Study Results from 1,003 People to Provide the Facts on Clinical Performance and to Support Public Health
Sep 21, 2020
Abbott Receives CE Mark for Next-Generation MitraClip(TM) Heart Valve Repair Device to Treat Mitral Regurgitation